This sensitisation effect was obtained by specifically inhibiting Nrf2, without the need to counteract additional detoxifying genes, indicating the significant role of Nrf2 family members in modulating drug response in B-ALL. This evidence concerns the gene NFE2L2 and acute lymphoblastic leukemia.